Rita Jain

Rita Jain has an estimated net worth of $4.43 Million. This is based on reported shares across multiple companies, which include ANAPTYSBIO, INC, ChemoCentryx, Inc., Immunovant, Inc., Akebia Therapeutics, Inc., Provention Bio, Inc., Celldex Therapeutics, Inc., Avalo Therapeutics, Inc., SAB Biotherapeutics, Inc., and First Tracks Biotherapeutics, Inc..

2026 was Rita Jain's most active year for acquiring shares with 14 total transactions. Rita Jain's most active month to acquire stocks was the month of March. 2022 was Rita Jain's most active year for disposing of shares, totalling 10 transactions. Rita Jain's most active month to dispose stocks was the month of September. 2026 saw Rita Jain paying a total of $16,242.07 for 376,304 shares, this is the most they've acquired in one year. In 2018 Rita Jain cashed out on 8,659 shares for a total of $77,411.46, their largest year based on trade value.